ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2026
Age- and time-specific management of traumatic anterior shoulder instability: The 2024 ESSKA-ESA Formal Consensus. Part 2: Treatment and return to sports.
Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The increasing presence and relevance of the shoulder in European Society for Sports Traumatology, Knee Surgery and Arthroscopy.Journal of experimental orthopaedics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo establish age- and time-specific recommendations for the treatment of traumatic anterior shoulder instability (TASI) and for return-to-sport (RTS) decision-making through a formal consensus process among European experts.
methodsThe European Society of Sports Medicine, Knee Surgery and Arthroscopy-European Shoulder Associates (ESSKA-ESA) formal consensus methodology was followed. A steering group formulated 35 clinically relevant questions, 23 of which addressed treatment and RTS and are reported in Part 2. A structured literature review was conducted. Statements were drafted and graded based on the level of scientific support. Then, the rating group reviewed and refined the statements, followed by validation from the reader group for cultural adaptability. Recommendations were tailored by age group (adolescents, young adults and older adults) and timing of instability (first-time vs. recurrent).
resultsThe final global median (range) of the 23 questions was 9 (8-9). Eleven questions achieved strong agreement, 11 relative agreement and 1 uncertain agreement. The grades of recommendations were: A in 0 (0%) statements, B in 30 (35.3%) statements, C in 24 (28.2%) statements and D in 31 (36.5%) statements (each statement could have more than one grade of recommendation). Bone loss and soft tissue lesions were key factors in decision-making. The consensus emphasized individualized thresholds for surgical versus conservative management, highlighting the role of bone augmentation in subcritical (bone loss 10%-15%) (especially in bipolar bone loss) and critical defects (bone loss >20%), lesion-specific soft tissue repair and the limited role of immobilization. RTS criteria included pain-free full range of motion, shoulder stability, strength and sport-specific readiness, typically achieved between 4 and 6 months depending on the procedure and sport demands.
conclusionsThis ESSKA-ESA European Formal Consensus delivers practical, evidence- and experience-based recommendations for treatment and RTS following TASI according to age- and time-specific (first time and recurrent) scenarios. By integrating recurrence status, bone loss, soft tissue injury and sport type, the consensus provides a clinically valuable framework for individualized decision-making. LEVEL OF EVIDENCE: Level II.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.